Recombinant Von Hippel Lindau Tumor Suppressor (vHL)

Recombinant Human Von Hippel Lindau Tumor Suppressor (vHL) is a purified Prokaryotic Protein. Purity: >80% by SDS-PAGE. Host: E. coli. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Human (Homo sapiens). Target Name: Von Hippel Lindau Tumor Suppressor (vHL). Target Synonyms: HRCA1; RCA1; VHL1; Von Hippel-Lindau Syndrome. Accession Number: P40337. Gene ID: 7428. Expression Region: Met1~Asp213. Tag Info: N-terminal His Tag. Theoretical MW: 35kDa. Buffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose. Storage: -20°C. Avoid repeated freeze/thaw cycles. Restrictions: For Research Use Only. Not for use in diagnostic procedures.